CastleKnight Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
23,243
-20,700
-47% -$1.49M 0.02% 337
2026
Q1
$3.13M Sell
43,943
-30,500
-41% -$2.09M 0.05% 233
2025
Q4
$4.41M Sell
74,443
-25,300
-25% -$1.37M 0.1% 124
2025
Q3
$5.5M Hold
99,743
0.11% 138
2025
Q2
$4.3M Buy
99,743
+25,843
+35% +$997K 0.12% 134
2025
Q1
$2.93M Buy
+73,900
New +$3.27M 0.11% 112

Other funds holding NGVT

CastleKnight Management's NGVT Position: Q2 2026 in Review

CastleKnight Management reduced its Ingevity (NGVT) stake by 47% in Q2 2026, selling an estimated $1.49M and leaving 23,243 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #337.

CastleKnight Management first reported a position in NGVT in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.5M in Q3 2025. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • CastleKnight Management held 23,243 shares of Ingevity worth $1.74M as of Q2 2026.
  • CastleKnight Management sold 20,700 Ingevity shares in Q2 2026, an estimated $1.49M.
  • Ingevity made up 0.02% of CastleKnight Management's portfolio in Q2 2026, its #337 holding.
  • CastleKnight Management first reported a position in Ingevity in Q1 2025 and has held it in 6 quarters since.
  • CastleKnight Management's Ingevity position peaked at $5.5M in Q3 2025.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.